Interesting comments from Professor D’Agistino regarding how a Ketogenic Diet helps Angelmans Syndrome even though it’s a genetic disorder. A keto diet has been used for epilepsy for over 100 years.
Would it help for the other genetic disorders that NEU are planning to address.
from the 6 minute mark!
Ann: FDA approval for Angelman IND and Phase 2 trial, page-12
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.03 |
Change
0.700(4.29%) |
Mkt cap ! $2.176B | |||
| Open | High | Low | Value | Volume |
| $16.49 | $17.21 | $16.44 | $11.40M | 677.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4624 | $17.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.05 | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |